EVP-6124 is a novel partial agonist of ??7 neuronal nicotinic acetylcholine receptors (nAChRs); shows selectivity for ??7 nAChRs and did not activate or inhibit heteromeric ??4??2 nAChRs.
More Information Supplier PageEVP-6124 is a novel partial agonist of ??7 neuronal nicotinic acetylcholine receptors (nAChRs); shows selectivity for ??7 nAChRs and did not activate or inhibit heteromeric ??4??2 nAChRs.
More Information Supplier PageEtimizol was shown to relieve amnesia effectively in the origin of which there is the hypoxic component (hypobaric hypoxia, actinomycin D, mechanical injury of the brain).
More Information Supplier PageEtimizol was shown to relieve amnesia effectively in the origin of which there is the hypoxic component (hypobaric hypoxia, actinomycin D, mechanical injury of the brain).
More Information Supplier PageEtimizol was shown to relieve amnesia effectively in the origin of which there is the hypoxic component (hypobaric hypoxia, actinomycin D, mechanical injury of the brain).
More Information Supplier PageEtifoxine hydrochloride is potentiator of GABAA receptor function in cultured neurons.
More Information Supplier PageEtifoxine hydrochloride is potentiator of GABAA receptor function in cultured neurons.
More Information Supplier PageEtifoxine hydrochloride is potentiator of GABAA receptor function in cultured neurons.
More Information Supplier PageEtifoxine is potentiator of GABAA receptor function in cultured neurons.
More Information Supplier PageEbrotidine is a competitive H2-receptor antagonist (Ki= 127.5 nM) with a potent antisecretory activity and evidenced gastroprotection.
More Information Supplier Page
